Home
/ Chiasma
/ Competitors

Chiasma Competitors and Similar CompaniesClear all

Chiasma's competitors and similar companies include OptiNose, Alliance Pharma, Unither Pharmaceuticals and Medicago.

	Chiasma Chiasma is a biopharmaceutical company specializing in rare or chronic diseases.	OptiNose OptiNose develops nasal drug delivery technologies and combination drug-device therapies.	Alliance Pharma Alliance is an international pharmaceutical company.	Unither Pharmaceuticals Unither Pharmaceuticals is a company that engages in sterile unit-doses contract manufacturing.	Medicago Medicago is a biotechnology company.
Founding Date	Founding Date 2001	Founding Date 2000	Founding Date 1996	Founding Date 1993	Founding Date 1997
Type	Type Subsidiary	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech medical devices pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Needham, US HQ Ness Ziona, IL	Locations Morrisville, US HQ Oslo, NO Swindon, GB	Locations Wiltshire, GB HQ Paris, FR Düsseldorf, DE Milano, IT Singapore, SG Tres Cantos, ES see more	Locations Amiens, FR HQ Wuhan Shi, CN Colomiers, FR Coutances, FR Gannat, FR see more	Locations Québec, CA HQ Brampton, CA Québec, CA Québec, CA Québec, CA
Employees	Employees 48167% increase	Employees 2048% decrease	Employees 290	Employees 1,4801% increase	Employees 2646% decrease
Financial
Revenue (est.)	Revenue (est.) $1.1m (FY, 2020)	Revenue (est.) $78.2m (FY, 2024)	Revenue (est.) £178.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $61k (FY, 2020)	Cost of goods $7.2m (FY, 2024)	Cost of goods £68.2m (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $1m (FY, 2020)	Gross profit $71m (FY, 2024)	Gross profit £110.6m (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income ($74.8m) (FY, 2020)	Net income ($21.5m) (FY, 2024)	Net income (£10.7m) (FY, 2024)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 139.8m	Total funding raised $ 120.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A